Viewing Study NCT00992992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2025-12-26 @ 5:54 PM
Study NCT ID: NCT00992992
Status: COMPLETED
Last Update Posted: 2019-12-04
First Post: 2009-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Mantle-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) View
None Tositumomab View
None Tositumomab and Iodine I-131 tostumomab View
None Bexxar View
None Iodine-131 Anti-B1 Antibody View
None Mantle Cell View
None radioimmunotherapy View